Wall Street Analysts Think Ocular Therapeutix (OCUL) Could Surge 82.48%: Read This Before Placing a Bet

Shares of Ocular Therapeutix (OCUL) have gained 6.7% over the past four weeks to close the last trading session at $12.1, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $22.08 indicates a potential upside of 82.5%.The average comprises 12 short-term price targets ranging from a low of $18.00 to a high of $31.00, with a standard deviation of $4.23. While the lowest estimate indi ...